Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
25 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
28 Mar 24
8-K
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001
25 Mar 24
8-K
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
25 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Entry into a Material Definitive Agreement
14 Dec 23
8-K
Regulation FD Disclosure
1 Dec 23
8-K
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
26 Oct 23
8-K
Stoke Therapeutics Appoints Ian Smith to its Board of Directors
20 Sep 23
8-K
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
11 Apr 24
424B5
Prospectus supplement for primary offering
28 Mar 24
FWP
Free writing prospectus
27 Mar 24
424B5
Prospectus supplement for primary offering
26 Mar 24
SC TO-I/A
Issuer tender offer statement (amended)
5 Dec 23
SC TO-I/A
Issuer tender offer statement (amended)
17 Nov 23
SC TO-I/A
Issuer tender offer statement (amended)
9 Nov 23
SC TO-I
Issuer tender offer statement
2 Nov 23
S-8
Registration of securities for employees
13 Apr 23
S-8
Registration of securities for employees
22 Mar 23
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEF 14A
Definitive proxy
28 Sep 23
PRE 14A
Preliminary proxy
18 Sep 23
DEFA14A
Additional proxy soliciting materials
24 May 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
PRE 14A
Preliminary proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
Other
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
EFFECT
Notice of effectiveness
1 Jun 22
CORRESP
Correspondence with SEC
26 May 22
UPLOAD
Letter from SEC
25 May 22
EFFECT
Notice of effectiveness
21 Jul 20
CORRESP
Correspondence with SEC
16 Jul 20
UPLOAD
Letter from SEC
15 Jul 20
EFFECT
Notice of effectiveness
19 Jun 19
CORRESP
Correspondence with SEC
14 Jun 19
Ownership
SC 13D/A
Skorpios Trust
18 Apr 24
4
Change in insider ownership
18 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
4
Barry Ticho
3 Apr 24
4
Huw M. Nash
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Jonathan Allan
1 Apr 24
144
Notice of proposed sale of securities
28 Mar 24
4
Stephen J Tulipano
19 Mar 24